Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from Brucella spp. as Nasal Adjuvant Induces a Th1 Immune Response and Modulates the Th2 Allergic Response to Cow's Milk Proteins

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Ibañez, Andrés E ^a   Smaldini, Paola ^b   Coria, Lorena M ^a   Delpino, María V ^a   Pacífico, Lucila G G ^c   Oliveira, Sergio C ^c   Risso, Gabriela S ^a   Pasquevich, Karina A ^a   Fossati, Carlos Alberto ^a,b   Giambartolomei, Guillermo H ^a   Docena, Guillermo H ^b   Cassataro, Juliana ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MILK PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 16; OVALBUMIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC REACTION; ANIMAL CELL; ARTICLE; BRUCELLA; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATORY CELL; INTERNALIZATION; LUNG LAVAGE; LYMPHOCYTE; MILK; MILK ALLERGY; MONOCYTE; NEUTROPHIL; NONHUMAN; NOSE MUCOSA; SPLEEN CELL; SYMPTOMATOLOGY; TH1 CELL; TH2 CELL; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; BACTERIAL OUTER MEMBRANE PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; BRUCELLA; CATTLE; CENTRAL NERVOUS SYSTEM; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LUNG; MICE; MILK HYPERSENSITIVITY; MILK PROTEINS; NASAL MUCOSA; SPLEEN; TH1 CELLS; TH2 CELLS;

BRUCELLA; MUS;

EID: 84879828235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069438     Document Type: Article

References (31)

1. Lawson LB, Norton EB, Clements JD, (2011) Defending the mucosa: adjuvant and carrier formulations for mucosal immunity. Curr Opin Immunol 23: 414-420. doi:10.1016/j.coi.2011.03.009. PubMed: 21511452.
2. Freytag LC, Clements JD, (2005) Mucosal adjuvants. Vaccine 23: 1804-1813. doi:10.1016/j.vaccine.2004.11.010. PubMed: 15734046.
3. Reed SG, Bertholet S, Coler RN, Friede M, (2009) New horizons in adjuvants for vaccine development. Trends Immunol 30: 23-32. doi:10.1016/j.it.2008.09.006. PubMed: 19059004.
4. Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, et al. (2004) Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350: 896-903. doi:10.1056/NEJMoa030595. PubMed: 14985487.
5. Steinhagen F, Kinjo T, Bode C, Klinman DM, (2011) TLR-based immune adjuvants. Vaccine 29: 3341-3355. doi:10.1016/j.vaccine.2010.08.002. PubMed: 20713100.
6. Carozzi S, Salit M, Cantaluppi A, Nasini MG, Barocci S, et al. (1989) Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol 27: 1748-1753. PubMed: 2504774.
7. Henricson BE, Manthey CL, Perera PY, Hamilton TA, Vogel SN, (1993) Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect Immun 61: 2325-2333. PubMed: 8388859.
8. Myers KR, Beining P, Betts M, Snippe H, Inman J, et al. (1995) Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier for hapten-specific antibody responses in mice. Infect Immun 63: 168-174. PubMed: 7806354.
9. Hessel EM, Chu M, Lizcano JO, Chang B, Herman N, et al. (2005) Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J Exp Med 202: 1563-1573. doi:10.1084/jem.20050631. PubMed: 16314434.
10. Johansen P, Senti G, Martinez Gomez JM, Storni T, von Beust BR, et al. (2005) Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy. Clin Exp Allergy 35: 1591-1598. doi:10.1111/j.1365-2222.2005.02384.x. PubMed: 16393325.
11. Crameri R, Rhyner C, (2006) Novel vaccines and adjuvants for allergen-specific immunotherapy. Curr Opin Immunol 18: 761-768. doi:10.1016/j.coi.2006.09.001. PubMed: 17010585.
12. Sicherer SH, Teuber S, (2004) Current approach to the diagnosis and management of adverse reactions to foods. J Allergy Clin Immunol 114: 1146-1150. doi:10.1016/j.jaci.2004.07.034. PubMed: 15536423.
13. Sampson HA, Anderson JA, (2000) Summary and recommendations: Classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children. J Pediatr Gastroenterol Nutr 30 (Suppl):: S87-S94. doi:10.1097/00005176-200001001-00013. PubMed: 10634304.
14. Host A, (1994) Cow's milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects. Pediatr Allergy Immunol 5: 1-36. doi:10.1111/j.1399-3038.1994.tb00210.x.
15. Cianferoni A, Muraro A, (2012) Food-induced anaphylaxis. Immunol Allergy Clin North AM 32: 165-195. doi:10.1016/j.iac.2011.10.002. PubMed: 22244239.
16. Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, et al. (2010) The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis. J Immunol 184: 5200-5212. doi:10.4049/jimmunol.0902209. PubMed: 20351187.
17. Zygmunt BM, Rharbaoui F, Groebe L, Guzman CA, (2009) Intranasal immunization promotes th17 immune responses. J Immunol 183: 6933-6938. doi:10.4049/jimmunol.0901144. PubMed: 19890060.
18. Seder RA, Hill AV, (2000) Vaccines against intracellular infections requiring cellular immunity. Nature 406: 793-798. doi:10.1038/35021239. PubMed: 10963610.
19. De Souza Rebouças J, Esparza I, Ferrer M, Sanz ML, Irache JM, et al. (2012) Nanoparticulate adjuvants and delivery systems for allergen immunotherapy. J Biomed Biotechnol, 2012(2012): 474605. PubMed: 22496608.
20. Hurtado PR, Jeffs L, Nitschke J, Patel M, Sarvestani G, et al. (2008) CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. BMC Immunol 9: 34. doi:10.1186/1471-2172-9-34. PubMed: 18625057.
21. Cox JC, Coulter AR, (1997) Adjuvants--a classification and review of their modes of action. Vaccine 15: 248-256. doi:10.1016/S0264-410X(96)00183-1. PubMed: 9139482.
22. Cox E, Verdonck F, Vanrompay D, Goddeeris B, (2006) Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet Res 37: 511-539. doi:10.1051/vetres:2006014. PubMed: 16611561.
23. Schijns VE, (2000) Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 12: 456-463. doi:10.1016/S0952-7915(00)00120-5. PubMed: 10899018.
24. Pashine A, Valiante NM, Ulmer JB, (2005) Targeting the innate immune response with improved vaccine adjuvants. Nat Med 11: S63-S68. doi:10.1038/nm1210. PubMed: 15812492.
25. Sesardic D, (2006) Regulatory considerations on new adjuvants and delivery systems. Vaccine 24 (Suppl 2):: S2-86-87. PubMed: 16823940.
26. Sampson HA, (1999) Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 103: 717-728. doi:10.1016/S0091-6749(99)70411-2. PubMed: 10329801.
27. Giambartolomei GH, Zwerdling A, Cassataro J, Bruno L, Fossati CA, et al. (2004) Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol 173: 4635-4642. PubMed: 15383598.
28. Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, et al. (2009) Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 77: 436-445. doi:10.1128/IAI.01151-08. PubMed: 18981242.
29. Garcia TC, Fonseca CT, Pacifico LG, Duraes Fdo V, Marinho FA, et al. (2008) Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice. Acta Trop 106: 162-167. doi:10.1016/j.actatropica.2008.03.003. PubMed: 18423420.
30. Smaldini P, Curciarello R, Candreva A, Rey MA, Fossati CA, et al. (2012) In vivo Evidence of Cross-Reactivity between Cow's Milk and Soybean Proteins in a Mouse Model of Food Allergy. Int Arch Allergy Immunol 158: 335-346. doi:10.1159/000333562. PubMed: 22472742.
31. Ceska M, Lundkvist U, (1972) A new and simple radioimmunoassay method for the determination of IgE. Immunochemistry 9: 1021-1030. doi:10.1016/0019-2791(72)90112-7. PubMed: 4538963.